{
  "trial_id": "NCT04514718",
  "overall_assessment": "likely_ineligible",
  "inclusion": [],
  "exclusion": [
    {
      "criterion": "calculation",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "Selection criteria Men over 50 Patients receiving HoLEP due to an enlarged prostate",
      "label": "does_not_trigger",
      "evidence": "none"
    },
    {
      "criterion": "Patients who fully understood and agreed to the study",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "function (Parkinson's disease, dementia, etc.) Patients with acute urinary retention",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "within the last month Patients with symptomatic urinary tract infection In case there",
      "label": "does_not_trigger",
      "evidence": "none"
    },
    {
      "criterion": "are other factors that can significantly affect treatment results at the discretion of the researcher",
      "label": "unknown",
      "evidence": "quote"
    },
    {
      "criterion": "Number of research subjects About 90 patients",
      "label": "does_not_trigger",
      "evidence": "none"
    },
    {
      "criterion": "The basis for calculating the number of subjects This study aims to prospectively enroll and randomize prostatectomy patients, and then compare the results of the treatment at 6 months after the maximum operation to confirm non-inferiority.",
      "label": "does_not_trigger",
      "evidence": "none"
    },
    {
      "criterion": "The current standard is a method using a high-energy holmium laser, and the treatment results for 6 months after surgery have been published through many studies. The research team wants to confirm the surgical outcome as a decrease in the International Prostate Symptom Score (IPSS). After 6 months of predicted high-energy HoLEP, IPSS in other literature (5.1 \u00b1 5.0), 6 months after the expected of low-energy HoLEP. IPSS is estimated from the most recently published academic paper (5.0 \u00b1 5.0).",
      "label": "does_not_trigger",
      "evidence": "none"
    },
    {
      "criterion": "Alpha (0.15) and Beta (0.8) were calculated, and the non-inferior margin was set to 3. The estimated number of subjects is calculated by considering the 20% drop-out rate.",
      "label": "does_not_trigger",
      "evidence": "none"
    },
    {
      "criterion": "Statistics for calculating the number of subjects are calculated using PASS 2019.",
      "label": "does_not_trigger",
      "evidence": "none"
    },
    {
      "criterion": "Considering drop-out 20%, it is necessary to recruit 25-114 patients (total 50-114) per group to conduct the study.",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "This organization is an organization that implements about 20-30 HoLEP cases per month, and a follow-up period of up to 6 months is required to announce short-term and mid-term results.",
      "label": "does_not_trigger",
      "evidence": "none"
    },
    {
      "criterion": "Therefore, the actual patient enroll period is estimated to be up to 6 months. It is expected that 120-180 patients can undergo surgery during the recruitment period of up to 6 months, and assuming that only 60% of patients will participate in the study based on the median of about 150, a total of 90 patients, about 45 for each group.",
      "label": "does_not_trigger",
      "evidence": "none"
    },
    {
      "criterion": "It is judged realistic to conduct a study with 3 patients.",
      "label": "triggers",
      "evidence": "quote"
    }
  ],
  "notes": "The patient has a history of BPH and multiple urological procedures, including suprapubic prostatectomy. He currently has a severe bulbar urethral stricture that requires surgical fixation.",
  "_meta": {
    "topic_id": "18",
    "trial_id": "NCT04514718",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}